El fadili, M., Er-Rajy, M., Kara, M., Assouguem, A., Belhassan, A., Alotaibi, A., . . . Elhallaoui, M. (2022). QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia. Pharmaceuticals (14248247), 15(6), 670. https://doi.org/10.3390/ph15060670
Chicago Style (17th ed.) CitationEl fadili, Mohamed, et al. "QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia." Pharmaceuticals (14248247) 15, no. 6 (2022): 670. https://doi.org/10.3390/ph15060670.
MLA (9th ed.) CitationEl fadili, Mohamed, et al. "QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia." Pharmaceuticals (14248247), vol. 15, no. 6, 2022, p. 670, https://doi.org/10.3390/ph15060670.
